Nordic Nanovector appoints Dr Lisa Rojkjaer, MD as Chief Medical Officer
Oslo, Norway, 15 November 2016 Nordic Nanovector ASA (OSE: NANO) is pleased to announce that Lisa Rojkjaer, MD has joined the company today as Chief Medical Officer (CMO) and as a member of the Executive Management Team. Dr Rojkjaer will lead all clinical development strategy and execution and support the company’s efforts to identify opportunities to expand its pipeline of innovative targeted therapies for haematological cancers. Dr Rojkjaer is a board-certified haematologist with more than 15 years of global and regional clinical development and medical affairs expertise in the